High expression of VEGF and PI3K in glioma stem cells provides new criteria for the grading of gliomas

Experimental and Therapeutic Medicine

Volumn 11, Issue 2, 2016, Pages 571-576

  Wang, Lei ^a,b   Zhang, Luyao ^a   Shen, Weigao ^b   Liu, Yanbo ^b   Luo, Yinan ^a  

^a Basic Medical College   (China)

^b BEIHUA UNIVERSITY   (China)

Author keywords

Cancer stem cells; Disease grading; Glioma

Indexed keywords

BIOLOGICAL MARKER; CD133 ANTIGEN; MESSENGER RNA; NESTIN; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR SOX2; VASCULOTROPIN;

ADULT; ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; GLIOMA CELL LINE; GLIOMA STEM CELL; HUMAN; HUMAN TISSUE; MALE; OLIGODENDROGLIOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

EID: 84950977258     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2906     Document Type: Article

References (53)

1. Mamelak AN and Jacoby DB: Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 4: 175-186, 2007.
2. Goodenberger ML and Jenkins RB: Genetics of adult glioma. Cancer Genet 205: 613-621, 2012.
3. Smoll NR, Gautschi OP, Schatlo B, Schaller K and Weber DC: Relative survival of patients with supratentorial low-grade gliomas. Neuro Oncol 14: 1062-1069, 2012.
4. Olson JD, Riedel E and DeAngelis LM: Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54: 1442-1448, 2000.
5. Ohgaki H and Kleihues P: Population-based studies on incidence, survival rates and genetic alterations in astrocytic and oligodendroglial glioma. J Neuropathol Exp Neurol 64: 479-489, 2005.
6. Plaks V, Kong N and Werb Z: The cancer stem cells niche: How essential is the niche in regulating stemness of tumor cells? Cell Stem Cell 16: 225-238, 2015.
7. Wang L, Xue Y, Shen Y, Li W, Cheng Y, Yan X, Shi W, Wang J, Gong Z, Yang G, et al: Claudin 6: A novel surface marker for characterizing mouse pluripotent stem cells. Cell Res 22: 1082-1085, 2012.
8. Gilbertson RJ and Rich JN: Making a tumour's bed: Glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7: 733-736, 2007.
9. Chen L, Chen XR, Chen FF, Liu Y, Li P, Zhang R, Yan K, Yi YJ, Xu ZM and Jiang XD: MicroRNA-107 inhibits U87 glioma stem cells growth and invasion. Cell Mol Neurobiol 33: 651-657, 2013.
10. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi A: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021, 2004.
11. Gaedicke S, Braun F, Prasad S, Machein M, Firat E, Hettich M, Gudihal R, Zhu X, Klingner K, Schüler J, et al: Noninvasive positron emission tomography and fluorescence imaging of CD133+ tumor stem cells. Proc Natl Acad Sci USA 111: E692-E701, 2014.
12. + population in human glioma. Cancer Cell 25: 64-76, 2014.
13. Jin X, Jin X, Jung JE, Beck S and Kim H: Cell surface nestin is a biomarker for glioma stem cells. Biochem Biophys Res Commun 433: 496-501, 2013.
14. Dell'Albani P: Stem cell markers in gliomas. Neurochem Res 33: 2407-2415, 2008.
15. Strojnik T, Røsland GV, Sakariassen PO, Kavalar R and Lah T: Neural stem cell markers, nestin and musashi proteins, in the progrssion of human glioma: Correlation of nestin with prognosis of patient survival. Surg Neurol 68: 133-143, 2007.
16. Raso A, Negri F, Gregorio A, Nozza P, Mascelli S, De Marco P, Merello E, Milanaccio C, Ravegnani M, Cama A, et al: Successful isolation and long-term establishment of a cell line with stem cell-like features from an anaplastic medulloblastoma. Neuropathol Appl Neurobiol 34: 306-315, 2008.
17. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M and Kornblum HI: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100: 15178-15183, 2003.
18. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD and Steindler DA: Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39: 193-206, 2002.
19. Dolgova EV, Alyamkina EA, Efremov YR, Nikolin VP, Popova NA, Tyrinova TV, Kozel AV, Minkevich AM, Andrushkevich OM, Zavyalov EL, et al: Identification of cancer stem cells and a strategy for their elimination. Cancer Biol Ther 15: 1378-1394, 2014.
20. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, Aigner L, Brawanski A, Bogdahn U and Beier CP: CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015, 2007.
21. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760, 2006.
22. Ma C, Li Y, Zhang X, Zhao G and Xu H: Levels of vascular endothelial growth factor and matrix metalloproteinase-9 proteins in patients with glioma. J Int Med Res 42: 198-204, 2014.
23. Li Q, Qiao G, Ma J and Li Y: Downregulation of VEGF expression attenuates maligant biological behavior of C6 glioma stem cells. Int J Oncol 44: 1581-1588, 2014.
24. Plate KH, Breier G, Millauer B, Ullrich A and Risau W: Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53: 5822-5827, 1993.
25. Das S and Marsden PA: Angiogenesis in glioblastoma. N Engl J Med 369: 1561-1563, 2013.
26. Whitman M, Downes CP, Keeler M, Keller T and Cantley L: Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332: 644-646, 1988.
27. Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signaling pathway and cancer. Cancer Treat Rev 30: 193-204, 2004.
28. Shin BC, Suzuki M, Inukai K, Anai M, Asano T and Takata K: Multiple isoforms of the regulatory subunit for phosphatidylinositol 3 kinase (PI3-kinase) are expressed in neurons in the rat brain. Biochem Biophys Res Commun 246: 313-319, 1998.
29. Weller M, Weber RG, Willscher E: Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome-and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol 129: 679-693, 2015.
30. Simonetti G, Gaviani P, Botturi A, Innocenti A, Lamperti E and Silvani A: Clinical management of grade III oligodendroglioma. Cancer Manag Res 7: 213-223, 2015.
31. Zhang C, Bao Z, Zhang W and Jiang T: Progress on molecular biomarkers and classification of malignant gliomas. Front Med 7: 150-156, 2013.
32. Kahramancetin N and Tihan T: Aggressive behavior and anaplasia in pleomorphic xanthoastrocytoma a plea for a revision of the current WHO classification. CNS Oncol 2: 523-530, 2013.
33. Schafer ML, Maurer MH, Synowitz M, Wustefeld J, Marnitz T, Streitparth F and Wiener E: Low-(WHO II) and anaplastic (WHO III) gliomas: Differences in morphology and MRI signal intensities. Eur Radiol 23: 2846-2853, 2013.
34. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
35. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neurophthol 114: 97-109, 2007.
36. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 15 Suppl 2: ii1-ii56, 2013.
37. Olar A and Aldape KD: Biomarkers classification and therapeutic decision-making for malignant gliomas. Curr Treat Options Oncol 13: 417-436, 2012.
38. Ichimura K: Molecular pathogenesis of IDH mutations in gliomas. Brain Tumor Pathol 29: 131-139, 2012.
39. Birner P, Pusch S, Christov C, Mihaylova S, Toumangelova-Uzeir K, Natchev S, Schoppmann SF, Tchorbanov A, Streubel B, Tuettenberg J and Guentchev M: Mutant IDH1 inhibits PI3K/Akt signaling in human glioma. Cancer 120: 2440-2447, 2014.
40. Olson RA, Brastianos PK and Palma DA: Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: A systematic review and meta-analysis. J Neuroncol 105: 325-335, 2011.
41. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Eng J Med 352: 997-1003, 2005.
42. Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, et al: MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26: 2192-2197, 2008.
43. Ohgaki H and Kleihues P: Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170: 1445-1453, 2007.
44. Bonnet D and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737, 1997.
45. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003.
46. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003.
47. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 445: 106-110, 2007.
48. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH and Nephew KP: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320, 2008.
49. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037, 2007.
50. Maitland NJ and Collins AT: Prostate cancer stem cells: A new target for therapy. J Clin Oncol 26: 2862-2870, 2008.
51. Temple S: Division and differentiation of isolated CNS blast cells in microculture. Nature 340: 471-473, 1989.
52. Reynolds BA, Tetzlass W and Weiss S: A Multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 12: 4564-4574, 1992.
53. Reynolds BA and Weiss A: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710, 1992.